Open access · CC-BY
via OpenAlex
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
Min-Tser Liao, Chia‐Chao Wu, Shu‐Fang Vivienne Wu, Mei‐Chen Lee, Wan‐Chung Hu, Kuo‐Wang Tsai, Chung‐Hsiang Yang, Chien‐Lin Lu, Sheng-Kang Chiu, Kuo‐Cheng Lu
Antioxidants · 2021 · ▲ 43 citations
Abstract
The coronavirus disease 2019 (COVID-19) pandemic continues to burden healthcare systems worldwide. COVID-19 symptoms are highly heterogeneous, and the patient may be asymptomatic or may present with mild to severe or fatal symptoms. Factors, such as age, sex, and comorbidities, are key determinants of illness severity and progression. Aging is accompanied by multiple deficiencies in interferon production by dendritic cells or macrophages in response to viral infections, resulting in dysregulation of inflammatory immune responses and excess oxidative stress. Age-related dysregulation of immune function may cause a more obvious pathophysiological response to SARS-CoV-2 infection in elderly patients and may accelerate the risk of biological aging, even after recovery. For more favorable treatment outcomes, inhibiting viral replication and dampening inflammatory and oxidative responses before induction of an overt cytokine storm is crucial. Resveratrol is a potent antioxidant with antiviral activity. Herein, we describe the reasons for impaired interferon production, owing to aging, and the impact of aging on innate and adaptive immune responses to infection, which leads to inflammation distress and immunosuppression, thereby causing fulminant disease. Additionally, the molecular mechanism by which resveratrol could reverse a state of excessive basal inflammatory and oxidative stress and low antiviral immunity is discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/antiox10091440
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Liao, M., Wu, C., Wu, S.V., Lee, M., Hu, W., Tsai, K., Yang, C., Lu, C., Chiu, S., & Lu, K. (2021). Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients. <em>Antioxidants</em>. https://doi.org/10.3390/antiox10091440
Vancouver
Liao M, Wu C, Wu SV, Lee M, Hu W, Tsai K, et al. Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients. Antioxidants. 2021. doi:10.3390/antiox10091440.
BibTeX
@article{mintser2021Resver,
title = {Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients},
author = {Min-Tser Liao and Chia‐Chao Wu and Shu‐Fang Vivienne Wu and Mei‐Chen Lee and Wan‐Chung Hu and Kuo‐Wang Tsai and Chung‐Hsiang Yang and Chien‐Lin Lu and Sheng-Kang Chiu and Kuo‐Cheng Lu},
journal = {Antioxidants},
year = {2021},
doi = {10.3390/antiox10091440},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Pharmaceutical Biotechnology 2025
Citation only
The Role of Immunosenescence and Inflammaging in the Susceptibility of Older Adults to SARS-CoV-2 Infection
Biomolecules 2021
Open access · CC-BY
Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients
Cells 2021
Open access · CC-BY
The Role of Immune Cells in Oxi-Inflamm-Aging
TSpace (University of Toronto) 2018
Preprint · OA
Generation of induced progenitor-like (iPL) cells using interrupted reprogramming
Psychoneuroendocrinology 2021
Citation only
Psychosocial stressors at work and inflammatory biomarkers: PROspective Quebec Study on Work and Health
Frontiers in Immunology 2020
Open access · CC-BY